SGRY - Company ID 0001638833
The table below shows Surgery Partners, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.31B | $3.11B | $2.74B | $2.54B | $2.23B | $1.86B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $118.20M |
Surgery Partners, Inc. reported annual revenue of $3.31B for fiscal year 2025. That is up 6.2% from $3.11B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $959.89M (FY 2015) to $3.31B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $138.70M |
| $120.90M |
| $102.20M |
| $104.00M |
| $97.10M |
| Operating income | $389.50M | $348.80M | $328.00M | $345.20M | $302.20M | $183.00M |
| Income tax | $18.00M | $134.60M | -$300.00K | $23.30M | $10.50M | -$20.10M |
| Net income | -$77.90M | -$168.10M | -$11.90M | -$54.60M | -$70.90M | -$116.10M |
| EPS (diluted) | -$0.61 | -$1.33 | -$0.09 | -$0.59 | -$1.12 | -$3.19 |